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Abstract
Background: Alternative transcription start site (TSS) usage plays important roles in transcriptional control of
mammalian gene expression. The growing interest in alternative TSSs and their role in genome diversification
spawned many single-gene studies on differential usages of tissue-specific or temporal-specific alternative TSSs.
However, exploration of the switching usage of alternative TSS usage on a genomic level, especially in the central
nervous system, is largely lacking.
Results: In this study, We have prepared a unique set of time-course data for the developing cerebellum, as part
of the FANTOM5 consortium (http://fantom.gsc.riken.jp/5/) that uses their innovative capturing of 5′ ends of all
transcripts followed by Helicos next generation sequencing. We analyzed the usage of all transcription start sites
(TSSs) at each time point during cerebellar development that provided information on multiple RNA isoforms
that emerged from the same gene. We developed a mathematical method that systematically compares the
expression of different TSSs of a gene to identify temporal crossover and non-crossover switching events. We
identified 48,489 novel TSS switching events in 5433 genes during cerebellar development. This includes 9767
crossover TSS switching events in 1511 genes, where the dominant TSS shifts over time.
Conclusions: We observed a relatively high prevalence of TSS switching in cerebellar development where the
resulting temporally-specific gene transcripts and protein products can play important regulatory and functional roles.
Keywords: Cerebellum, Developmental biology, Promoter, Promoter switching, HeliScopeCAGE, Alternative promoters,
Alternative splicing, Transcription start site
Background
Alternative splicing can provide a large reservoir of tran-
scriptional variants from the ~22,000 genes identified by
the Human Genome Project [1]. The production of dif-
ferent isoforms due to the usage of alternative transcrip-
tion start sites (TSSs), which was once considered as
uncommon, has now been found in the majority of
human genes [2, 3]. Alternative TSSs could be results of
a gene duplication event followed by the loss of func-
tional exons in the upstream copy and diversification of
the two duplicated promoters. Alternative TSS usage can
affect gene expression and generate diversity in a variety
of ways. On the transcriptional level, alternative TSS
could result in tissue-specific expression, temporally reg-
ulated expression, and the amplitude of expression. On
the post-transcriptional level, alternative TSS can affect
the stability and translational efficiency of the mRNA.
Furthermore, alternative TSS can result in protein iso-
forms with a different amino terminus, which can lead
to alterations in protein levels, functions, or subcellular
distribution. Therefore, the investigation of temporal
switching of TSSs can provide insights into the regula-
tion of different protein isoforms, and presumably their
differences in function. One way to optimally identify
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differential use of isoforms is to examine transcriptional
regulation over developmental time.
One high-throughput technique to survey gene ex-
pression at the transcriptome level is Cap Analysis Gene
Expression (CAGE) which generates a genome-wide ex-
pression profile based on sequences from the 5′ end of
the mRNA [4, 5]. In the FANTOM project, CAGE has
been shown to identify different TSSs and the corre-
sponding promoters for single genes [6–9]. With CAGE
data, one can infer the TSS usage through the number
of transcripts produced at that particular TSS. When
more than one TSS is used at a single time point from
a single gene, the TSS with highest expression is con-
sidered the “dominant” TSS. The understanding of how
the TSS usage changes during development can shed
light on how a single gene can function differently over
developmental stages through temporally regulated al-
ternative mRNA and protein isoforms.
The complexity of brain development requires intri-
cately controlled expression of specific genes across
time. The cerebellum is often used as a model in ana-
lyses of brain development due to its limited number of
major cell types. These cells are positioned in spatially
defined territories of the developing cerebellum. The
cerebellum has also been the focus of two extensive
genome-wide gene expression profiling of the developing
cerebellum [10, 11]. Detailed information on temporally
regulated promoter usage of developmentally important
genes - which is still largely lacking - can provide
valuable information on genome diversity. Moreover, dif-
ferent isoforms of these genes may be translated into
distinct protein products that perform different tasks.
Such analyses would give insight to the alterations made
to the form of the final transcript, localization for tran-
scription factors motif prediction, utilization, and associ-
ated regulatory network changes. Thus, in collaboration
with the FANTOM5 project [12], we generated a CAGE
dataset for the developing cerebellum with 12 time points
to study temporally-regulated gene expression and alter-
native TSS usage during cerebellar development.
TSS switching events across samples were systematically
identified by comparing differential promoter transcrip-
tion levels between pairs of TSSs and pairs of develop-
mental time points, and by applying the Silvapulle FQ test,
a statistical method for constrained hypothesis testing that
we specifically apply for the detection of crossover TSS
switching events [13]. The FQ test produces p-values to es-
timate significance of a crossover switching event. We
have applied the FQ test to our cerebellar time series to
identify novel TSS switching events during cerebellar de-
velopment. Our hypothesis was that differential TSS usage
can result in significant regulatory changes that underlie
cellular events critical for cerebellar development and
morphogenesis. By taking advantage of the FANTOM5
collaboration with our cerebellar developmental time
course, we identified 48,489 novel TSS switching events,
including 9767 events in which the dominant TSS shifts
over time. These TSS switching events were predicted to
produce temporally-specific gene transcripts and protein
products that can play important regulatory and func-
tional roles during cerebellar development.
Methods
Mouse colony maintenance and breeding
This research was performed with ethics approval from
the Canadian Council on Animal Care and research con-
ducted in accordance with protocol A12–0190. C57BL/
6 J mice were used in all experiments and were imported
from The Jackson Laboratory (Maine, US) and main-
tained in our colony as an inbred line. To standardize
the time of conception, timed pregnancies were set up.
Every weekday at 10:00 am, females were coupled with
male; at 3:00 pm, the females were checked for vaginal
plugs and removed from their partners. The appearance
of a vaginal plug was recorded as the day of conception
(i.e. embryonic day 0) and embryos were collected at
10 am on embryonic day 11–18 (E11-E18) every day and
postnatal day 0–9 (P0-P9) every 3 days for a total of 12
time points in our cerebellar time series.
Tissue processing
On the day of embryo collection, the mothers were
sacrificed and embryos were removed from the uterus in
ice-cold RNAse-free PBS. Cerebella were dissected from
the head of the embryos, then pooled with littermates,
and snap-frozen in liquid nitrogen. Three replicate pools
of whole cerebella samples were collected at each time
point. The standard TRIzol RNA extraction protocol
[14] was used for tissue homogenization and RNA
extraction.
Quality assessment
A Bioanalyzer (Agilent, Santa Clara, CA) was used to
examine RNA quality. All RNA samples used for the
time series achieved high RNA Integrity (RIN) scores
above 9.0. The samples were sent to RIKEN Omics Center
at Yokohama, Japan, as part of Functional Annotation of
the Mammalian Genome 5 (FANTOM5) collaboration for
CAGE analysis.
Transcriptome library generation by HeliScopeCAGE
CAGE is a technique that generates a genome-wide ex-
pression profile based on sequences from the 5′ end of
the mRNA. With CAGE, the first 27 bp from the 5′ end
of RNAs were extracted and reverse-transcribed to DNA
[4]. The short DNA fragments were then systematically
sequenced with the Helicos platform [15]. Each se-
quenced tag was then mapped to the reference genome
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to identify the transcription start site (TSS) of the gene
from which it was transcribed. “Tag per million” (tpm)
was used as a measure of the expression level of RNAs
based on concentration – an expression of “10tpm”
means that out of each million total transcripts, 10 were
transcribed from the TSS in question. Alternative TSSs
(illustrated in Fig. 1a) can be detected when multiple
CAGE tags are mapped to the same gene locus in the
reference genome. Mapped CAGE tags can be clustered
into promoter regions after thresholding to determine
bona fide promoter regions in the genome. For this
analysis, we use the list of promoter regions published
by the FANTOM5 Consortium [5].
TSS switch detection
TSS switching events are detected by comparing the ex-
pression of transcripts from two TSSs of a single gene at
two time points. The difference in expression level of
the two TSSs is designated d1 and d2 at time point 1
and time point 2, respectively. The null hypothesis is
that there is no switching for the two TSSs (d1 = d2, see
Fig. 1b). The test of this hypothesis was performed using
the standard t-test, with candidate switching events
identified at this preliminary stage if the adjusted p-value
was <0.2. A non-crossover TSS event is detected if one
TSS is used more frequently at one time point compared
to the other, but the same TSS is used dominantly at
both time points (d1 > d2, or d1 < d2, both d1 and d2
same sign, Fig. 1b). A crossover TSS switching event is
detected if one TSS is used more frequently at one time
point compared to the other, and that the dominant TSS
switches at the two time points (d1 > 0 and d2 < 0 or
d1 < 0 and d2 > 0, Fig. 1b). In order to reduce potential
confounding of TSS switching events by differential ag-
gregate promoter expression between time points, candi-
date events were further limited to TSS pairs that do not
change in overall mean expression between developmen-
tal stages being compared. The null hypothesis tested at
this stage is that the mean TSS expression at the two
time points is equal, and results were filtered out if the
t-test adjusted p-value was <0.1.
In addition to the differences in expression (d1,d2),
the results of TSS switching are represented using the
FQ statistic [12] which formally tests for the presence of
crossover switching for each gene. The test of the null
hypothesis of no differential crossover promoter usage
corresponds to a test involving the FQ statistic, which is
functionally similar to the ANOVA F-test. Exact p-values
for this test are obtained as described in Silvapulle [12].
To our knowledge, the Silvapulle FQ test is the only
statistical test available that was specifically developed
for testing hypotheses regarding qualitative interaction,
and which we apply in the current study for testing the
presence of crossover switching in gene promoter
usage.
All P-values are adjusted for multiple comparisons
using the Benjamini–Hochberg method to control the
false discovery rate. The P-value of the FQ test was used
as an indicator of significance for choosing biological
validation candidates.
Fig. 1 A schematic diagram of alternative transcription start sites (TSSs) and the classes of TSS switching. a Alternative TSSs can generate different
splicing variants that can be translated into different protein isoforms. *the functional domains may be affected by alternative TSSs which results
in functional diversity. b Different outcomes comparing alternative TSS usage at two time points – no TSS switching, non-crossover TSS switching
or crossover TSS switching. Y-axis represents the quantitative measure of TSS usage measured by the expression level of its mRNA transcript. X-axis
represents the two developmental time points used in the comparison (t1 vs. t2)
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Gene ontology analysis for gene with crossover switching
events
To identify cellular processes and molecular pathways in
genes with crossover TSS switching events, we used
Database for Annotation, Visualization and Integrated
Discovery program (DAVID, https://david.ncifcrf.gov/
[16]) to examine the gene ontology of genes with at least
one crossover event with p < 0.05 in FQ test. Top 20 GO
terms were used for overall analysis in crossover TSS
switching genes during cerebellar development. Further-
more, for temporal functional analysis of crossover TSS
switching events, top 20 GO terms were generated with
DAVID for all events associated with three developmen-
tal time points – E13, E15 and P0.
In silico validation of gene expression with established
databases and experimental validation with gene
structure prediction and quantitative real-time PCR
We used online databases to examine the 20 genes with
the lowest p-values. First, we used in situ resources -
Genepaint (http://genepaint.org [17]) and Allen Brain
Atlas (http://www.brain-map.org [18]) to examine the
genes’ expression in the cerebellum. Second, we examined
the predicted mRNA structures from the two TSSs with
the intron/exon database Aceview (http://www.ncbi.nlm.
nih.gov/IEB/Research/Acembly/ [19]) as well as functional
domains of their protein products from protein domain
database PhosphoSitePlus (http://www.phosphosite.org
[20]) to determine the potential effect of TSS switching
events on biological function.
Three genes were chosen for further validation for
TSS-specific quantitative real-time PCR for the valid-
ation of alteration in TSS usage at E12, E15 and P9.
Cerebellar RNA was extracted from C57BL/6 J mice at
E12, E15 and P9 following the same procedure that were
used for HeliScopeCAGE RNA collection. cDNAs were
produced with random hexamers using the High Capa-
city cDNA Archive Kit (Applied Biosystems). cDNA
products were diluted to 100 ng total RNA input.
Sequences of the transcript of interest were loaded into
Primer Express® software (Applied Biosystems). For each
gene, an isoform-specific forward primer was designed
for each of the long and short isoform, while the reverse
primer aligns to a common sequence that is shared by
both isoforms. Amplicon lengths were between 80 and
120 bp. The qPCR was performed with the FAST SYBR
Green PCR Master Mix (Applied Biosystems) on an ABI
StepOne Plus Sequence Detection System (Applied
Biosystems). All runs were normalized to the control
gene, Gapdh. Three biological replicates were prepared
for each gene target and three technical replicates were
performed for each biological replicate. Gene expression
was represented as relative quantity against the negative
control which used water as the template (noted as
“Relative Quantity vs. H2O” in figures). The results of
Real-Time PCR were analyzed and graphed by ABI
StepOne Plus Sequence Detection System (Applied
Biosystems). The expression data were compared with
the HeliScope-CAGE data.
Results
Overview of promoter switch events during cerebellar
development
Our cerebellar time series, which consisted of transcrip-
tome data from 12 time points, yielded a total of
183,903,557 CAGE tags that are mapped to 25,207 genes
in the reference genome. We identified 48,489 TSS
switching events (Fig. 2a) in the cerebellar time series
data that occur in 5433 genes. These events are com-
prised of 38,722 non-crossover switching events (Fig. 2b)
that occur in 5293 genes, and 9767 crossover switching
events (Fig. 2c) that occur in 1511 genes. One thousand
three hundred seventy-one out of 1511 genes (~91%)
that have crossover TSS switching events also have at
least one non-crossover switching event. This indicates
that crossover TSS switching events are rarer and occur
in fewer genes when compared to the non-crossover
events.
When comparing the cerebellar TSS switching data to
nine other tissues in the FANTOM5 dataset (see Table
1; detailed descriptions about time series on these tissues
can be found in [12]), our cerebellar development time
series has the 3rd highest total number of TSS switching
events (48,489) behind “Epithelial to mesenchymal”
(132,661 events) and “Adipocyte differentiation” (66,087
events); and is the highest of the three samples derived
from ectoderm [“Human iPS to neuron (wt) 1” and
“Trachea epithelia differentiation”]. While the cerebellar
development time series has less total events than
“Epithelial to mesenchymal” and “Adipocyte differenti-
ation” samples, it has a higher frequency of crossover
TSS switching events - 20.1% vs 17.6 and 12.5%, re-
spectively. Interestingly, when compared to 48,489
events found in the cerebellum, four out of the five
remaining datasets had a higher percentage of crossover
events but a much lower number of total switching events.
In conclusion, cerebellar development showed a high
frequency in crossover TSS switching among datasets
with a high number of total switching events.
Distribution of TSS switching events in cerebellar
transcriptome
When we looked at the distribution of the 48,489 TSS
switching events over the 5433 genes, we found a ma-
jority of genes with few events and a minority of genes
with many events. Thus, we found there are 1534 (28%
of TSS switching gene) genes with one TSS switching
event; and only two genes with more than 800 switching
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events (Fig. 3a). When we looked at the top 20 genes with
the most TSS events (listed in Table 2), we observed that
these genes account for 13.5% for all TSS switching
events, or a total of 6567 events. From Fig. 3 (as well as
Table 2), we can see that there are two outlier genes that
have the largest number of TSS switching events for all 3
groups (all TSS, non-crossover and crossover, indicated by
arrows in Fig. 3a-c) - Frmd4a (FERM domain containing
4A) with a total of 852 TSS switching events and Ank3
(ankyrin 3) with a total of 801 TSS switching events (see
Table 2). These two genes have more than twice the num-
ber of TSS switching events than the next closest gene,
Abr (active BCR-related gene) with a total of 386 TSS
switching events. The numbers of TSS switching events
are more evenly distributed across the rest of the 18 genes
with a higher frequency of switching (see Fig. 3) as the dif-
ference between each rank is less than 10% of the number
of events in this group.
When comparing the distribution of crossover and non-
crossover events, we found that crossover switching events
are clustered in fewer genes when compared with non-
crossover events. Since the frequency of non-crossover
switching is about four times the number of cross-over
(38,722:9767 or 3.96:1), we would expect roughly a 4:1 ra-
tio for non-crossover: crossover events for any given gene,
assuming an even distribution of both categories. Indeed,
we observed roughly a 4:1 ratio for Ablim1 (204 non-
crossover events and 50 crossover events) and Dlg2
Fig. 2 Overview of TSS switching events during cerebellar development. a Overview of 48,489 TSS switching events during cerebellar
development. These events significantly deviate from the no-switching line (indicated by d1 = d2) (p < 0.05). b Overview of 38,722 non-crossover
TSS switching events during cerebellar development. c Overview of 9767 crossover TSS switching events during cerebellar development. X-axis
represents d1, which is the difference in expression between the two TSSs, measured in tags per million (tpm), at developmental time point 1
(t1), see Fig. 1b for a graphic illustration. Y-axis represents d2, which is the difference in expression between the two TSSs, measured in tag per
million (tpm) at developmental time point 2 (t2), see Fig. 1b for a graphic illustration
Table 1 Comparison of TSS switching events during cerebellar development with other FANTOM5 datasets
Time Series Germ layer TP# Switching# Gene# % Non-Xover % Xover %
Cerebellar development Ectoderm 12 48,489 5433 21.6 38,722 79.9 9767 20.1
Human iPS to neuron (wt) 1 Ectoderm 4 45,069 6692 26.5 41,302 91.6 3767 8.4
Trachea epithelia differentiation Endoderm 19 8389 2458 9.8 6112 72.9 2277 27.1
Adipocyte differentiation Mesoderm 16 66,087 5996 23.8 57,857 87.5 8230 12.5
Epithelial to mesenchymal Mesoderm 21 132,661 7004 27.8 109,252 82.4 23,409 17.6
BMM TB activation IL13 Mesoderm 11 825 527 2.1 564 68.4 261 31.6
AoSMC response to IL1b Mesoderm 10 192 159 0.6 129 67.2 63 32.8
Macrophage response to LPS Mesoderm 23 32,234 4557 18.1 22,239 69.0 9995 31.0
ES to cardiomyocyte Mesoderm 13 189 163 0.6 100 52.9 89 47.1
Myoblast to myotube Mesoderm 9 21,912 4249 16.9 18,735 85.5 3177 14.5
TP# number of time points in the time series, Switching # total number of TSS switching events found in the dataset, Gene # total number of genes with at least
one TSS switching event, Column 6: % TSS switching genes over all 25,207 genes, Non-Xover total number of non-crossover TSS switching events found in the
dataset, Column 8: % percentage of non-crossover events over all switching events, Xover total number of crossover TSS switching events found in the dataset,
Column 10: % percentage of crossover events over all switching events
Zhang et al. BMC Genomics  (2017) 18:461 Page 5 of 14
(223 non-crossover events and 43 crossover events,
Table 2). However, for the majority of the 20 genes with
the greatest number of switching events, the frequency
of crossover events is much higher than one fourth of the
non-crossover counterpart, such as the two outlier genes
mentioned above - Frmd4a (509 non-crossover events vs
343 crossover events) and Ank3 (464 non-crossover
events vs 337 crossover events, Table 2). This un-even dis-
tribution of crossover events is also reflected by the lower
abundance of genes with a low number of switching
events – 3052 genes have less than 3 non-crossover events
(Fig. 3b) and only 944 genes have less than 3 crossover
events (Fig. 3c). In conclusion, we found that crossover
events tend to cluster in a fewer number of genes when
compared to the non-crossover counterpart.
Gradual increment in the number of crossover TSS
switching events over developmental time
Next, we focused in the temporal distribution of cross-
over TSS switching. When we look at a day-to-day
change in promoter usage (E12 vs E11, E13 vs E12 etc.,
underlined in Table 3), TSS switching occurs evenly
across cerebellar development from 13 events to 39
events - with the exception of the E13-E12 comparison
(Table 3). There are 93 TSS switching events between
E12 and E13 indicating a major shift in promoter usage
at this developmental stage.
To examine the general pattern of TSS switching during
cerebellar development, we counted promoter switch
events by developmental time points (Table 3). Among the
12 data points in our time course, a total of 66 comparisons
between two data points have been carried out to search
for the switching of alternative TSSs (Table 3). Over the
time series, there is a general incremental number of cross-
over switching events that are detected between two sam-
ples that are temporally distant. This most likely reflects the
gradual shift of cerebellar transcriptome and TSS usage
during development. There are rare exceptions to this pat-
tern, for example, there are more switching events between
E11 and E17 samples than found between E11 and E18
samples.
Fig. 3 Distribution TSS switching events in different genes during cerebellar development. a Distribution 48,489 TSS switching events in genes
during cerebellar development. Arrow points to the two genes with more than 800 switching events. b Overview of 38,722 non-crossover TSS
switching events in 5293 genes during cerebellar development. c Overview of 9767 crossover TSS switching events in 1511 genes during cerebellar
development. x-axis – number of TSS events occurs within one gene (log2 scaled). y-axis – number of genes that have the number of TSS events
indicated on the x-axis
Table 2 Top 20 genes with highest numbers of TSS switching
events
Gene ID All events Non-crossover
events
Crossover events
1 Frmd4a 852 509 343
2 Ank3 801 464 337
3 Abr 386 275 111
4 Ednrb 356 211 145
5 Iqsec1 348 206 142
6 Bcat1 329 221 108
7 Pde4d 308 176 132
8 Ldb1 304 167 137
9 Sorbs2 297 175 122
10 Cnpy1 273 158 115
11 Dlg2 266 223 43
12 Ebf1 262 160 102
13 Ablim1 254 204 50
14 Zeb2 246 218 28
15 Trim2 233 168 65
16 Celf2 227 162 65
17 Map2 226 170 56
18 Itgb8 208 126 82
19 Ank2 197 126 71
20 Ptprg 194 111 83
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Gene ontology analysis for genes with the most
significant crossover TSS switching events
To functionally annotate the genes that undergo sig-
nificant crossover TSS switching, we used the Data-
base for Annotation, Visualization and Integrated
Discovery program (DAVID, https://david.ncifcrf.gov/
[16]) to examine the biological process and terms as-
sociated with crossover TSS switching genes. From
1509 genes with 9767 crossover TSS switching events
at p < 0.05, we analyzed 20 gene ontology (GO) terms
with the lowest p-value from the DAVID analysis (see
Fig. 4a). Terms associated with neuronal development,
such as “neuron development”, “neuron projection”
and “synapse” also showed up at high significance
levels from DAVID analyses (Fig. 4a).
We have found that the largest alteration in gene ex-
pression occurs at E13, E15 and P0 (manuscript in prep-
aration) and were interested to determine the extent
that crossover TSS switching plays a role in transcrip-
tome diversity. When comparing crossover events at E13
with all other time points we find 1440 significant
(p < .05) events in 584 genes. When comparing cross-
over events at E15 with other time points we find 1355
significant (p < 0.05) events in 582 genes. Finally, when
comparing crossover events at P0 with all other time
points we find 1152 significant (p < .05) events in 506
genes. We used these gene lists as input to DAVID and
the top 20 terms were selected for these temporal com-
parisons among the three time points (Fig. 4b). We
found that 7 terms (phosphoprotein, alternative splicing,
splice variant, cytoplasm, neuron projection, cytoskeletal
protein binding and cytoskeleton) were shared among
each of the three time points. These 7 GO terms were
also found among the 8 most significant terms in the
analysis with all genes discussed previously. We also ob-
served that comparisons between shorter time spans
yield more common GO terms –e.g., there are 5 terms
shared between genes with crossover TSS events at E13
and E15, 1 term between E15 and P0 and no terms were
common between E13 and P0. Lastly, the majority of
GO terms unique to a given time point shared a com-
mon theme that may reflect active biological process oc-
curring at the given time – e.g., four out of eight E13
terms were associated with cell motion and cytoskeleton;
five out of seven E15 terms were associated with ion
binding and six out of twelve P0 terms were associated
with regulation of intracellular organization.
Validation of promoter switching events
To further investigate the genes with the 20 most signifi-
cant TSS switching events, we used the in situ hybridization
expression database Genepaint (http://www.genepaint.org/)
to examine their expression pattern in the cerebellum
(summarized in Table 4). Three of these genes showed ro-
bust cerebellar expression (Gpc6, Anp32a and Cntnap2)
and were chosen to demonstrate the potential biological
roles of the TSS switching events during cerebellar develop-
ment. First, their mRNA structures were obtained from the
intron/exon database Aceview (http://www.ncbi.nlm.nih.
gov/IEB/Research/Acembly/); then their protein structure
for each isoform was obtained from protein domain data-
base PhosphoSitePlus (http://www.phosphosite.org); finally,
the TSS switching events for these three genes were vali-
dated with quantitative real-time PCR with promoter-
specific primers.
When we investigate the role of the most significant
TSS switching events, we found that some of the most
significant events do not seem to affect protein sequence
and may play roles in transcriptional or post-transcriptional
regulation. One example we examined is Glypican-6(Gpc6)
- a member of Glypican family that is found on the cell sur-
face and plays important roles in cellular growth control
and differentiation. The two TSS sites are 32 bp apart in
the genome and mRNA that originate from the two TSS
sites differ in the first exon in the 5’UTR region (Fig. 5a).
The two forms of mRNA were predicted to be translated
into the same protein isoform that contains 565 amino
acids. The single glypican domain that makes up the major-
ity of the peptide is not effected by the TSS switching event
(Fig. 5a). Therefore, the usage of alternative TSSs in Gpc6,
which is expressed in the NE, NTZ and EGL in the cerebel-
lum (Fig. 5b), could play a regulatory role, such as tempor-
ally regulated expression, amplitude of expression, mRNA
stability and mRNA translational efficiency. Our qRT-PCR
data confirmed the TSS switching prediction (Fig. 5c) and
showed that it undergoes a non-crossover TSS switching
between E15 (TSS2 is the dominant form and has >2 fold
usage compared with TSS1) and P9 (TSS2 has slightly
Table 3 Distribution of crossover TSS switching events across
time in cerebellar development (N = 9767)
E12 E13 E14 E15 E16 E17 E18 N0 N3 N6 N9
E11 31 180 290 340 320 333 236 291 354 279 429
E12 93 159 200 209 238 162 228 274 225 381
E13 21 59 99 97 76 118 190 180 327
E14 34 55 86 69 114 203 198 303
E15 35 30 29 56 129 143 301
E16 29 23 53 103 113 226
E17 13 39 58 91 204
E18 20 42 76 123
N0 39 60 134
N3 25 76
N6 17
Number of crossover TSS switching events that are found in adjacent time
points are in Bold
For example, 93 in column 3, row 3 represents 93 crossover events found
between E12 and E13
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higher usage than TSS1, but remains as the dominant form,
see Fig. 5d).
Some of the most significant TSS switching events
occur between two TSSs that could produce protein iso-
forms with different N-termini, which may or may not
affect the function of the protein isoforms. An example
of this would be Acidic (leucine-rich) nuclear phospho-
protein 32 family member A (Anp32a) - a member of
acidic nuclear phosphoprotein 32 kDa (Anp32) family.
The two TSS sites are 328 bp apart in the genome and
mRNA that originate from the two TSS sites differs in
the first exon in the 5′UTR region as well as the N-
terminus of protein products. The first 12 amino acids
of the long isoform were absent on the short isoform.
Functional domains were not affected by the TSS switch-
ing event - both isoforms retained two LRR4 domains
and a single NOP14 domain (Fig. 6a). The difference at
the N-terminus can lead to alterations in Anp32a’s pro-
tein level, subcellular distribution or function in the EGL
where it is strongly expressed (Fig. 6b). As predicted
(Fig. 6c) and validated with our qRT-PCR data, Anp32a
undergoes a crossover TSS switching between E12
(TSS9 as dominant form) and P9 (TSS 4 as dominant
form, see Fig. 6d).
Lastly, among the genes with the most significant TSS
switching events, we have discovered a crossover TSS
switching event where protein function is highly affected
in the Contactin-associated protein-like 2 (Cntnap2) – a
gene encodes a member of the neurexin family which
functions as cell adhesion molecules and receptors in
neurons. The two TSS sites, that lead to the transcrip-
tion of two NCBI-validated mRNA refseqs, are more
than 2 million bp apart in the genome. mRNAs that ori-
ginate from the two TSS sites differ by more than
6000 bp and consist of the first 20 exons of the long
mRNA – only 4 exons at the 3′ end of the long form
mRNA (NCBI Locus: NM_001004357.2) are present in
the short form (NCBI Locus: NM_025771.3, see Fig. 7a).
The Cntnap2 protein, in its long isoform (NCBI Locus:
NM_025771.3), contains 1400 amino acids and many
functional domains including one F5/8 type C domain,
two epidermal growth factor repeats domains, four
laminin G domains and a TM domain. The short protein
isoform of Cntnap2 (NCBI Locus: NP_080047.1), which
has 190 amino acids has only two of the eight functional
domains remaining, the last laminin G domain and the
TM domain (Fig. 7a). In the Genepaint database, a probe
specific to the long isoform of Cntnap2 was used, and it
Fig. 4 GO Analysis for genes significant (p < 0.05) for crossover switching at all time points (left) and at three selected time points (right). a Top
20 terms from GO analysis of all 9767 crossover TSS switching events in 1509 genes For column heading: “Term” is the GO term, “Count” is the
number of genes associated with the GO term and “%” is the fraction of the number of genes associated with the GO term divided by the total
input of 1509 genes, “PValue” and “Bonferroni” represent the significance of the GO term. b A Venn diagram comparing the top 20 GO terms
from crossover TSS switching events between all samples and either E13, E15 or P0 samples
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is indicated that the long isoform is primarily expressed
in the rhombic lip of the cerebellum at E14.5 (Fig. 7b).
According to our prediction (Fig. 7c) and qRT-PCR
results, Cntnap2 undergoes a crossover TSS switching
between E15 (TSS4 as dominant form) and P9 (TSS3 as
dominant form, see Fig. 7d). The highly differentiated
protein isoforms of Cntnap2 suggest the gene’s temporal
shift in protein functions during cerebellar development
where a truncated form is made specifically in the during
early embryonic stages.
Discussion
High prevalence of alternative TSSs in mammalian
genomes
In this study, we have identified 5293 genes (~21% of a
total of 25,207 genes) that exhibit differential TSS usage
during cerebellar development. These findings are in line
with previous studies and indicate that TSS switching
events are common and can play an important role in
the diversity of the cerebellar transcriptome during de-
velopment [21–23]. Furthermore, we have identified
9767 crossover TSS switching events which suggests an
alteration in the dominant TSS over time. Since the
alternative mRNA isoforms could be translated into
functionally different products, a crossover switching
event suggests that one gene can play different roles at
different time points in development.
Alternative usage of multiple TSSs of one gene is com-
mon in mammalian genomes. It is a key mechanism to
increase mRNA and protein diversity since multiple
mRNAs from a single gene can encode distinct protein
isoforms with different functions (reviewed in [24]).
Recent studies suggest that about half of the mouse
genes have multiple alternative promoters [25, 26]. For
example, alternative promoters have been identified in
>20% of genes in ENCODE (http://genome.ucsc.edu/
ENCODE/) regions [6]. Other genomic studies also
found more than a quarter of human genes having mul-
tiple active promoters [27–29]. The complex transcrip-
tional regulation of alternative promoter usage has
been identified in several genes [24]. Furthermore, in
some genes, such as tumor protein p53 (TP53) and
Table 4 Cerebellar expression patterns of genes with most significant switching events at E14.5 from the in situ database,
Genepaint
Gene Full name Genepaint
DLG3 discs, large homolog 3 N/E
SLC12A5 solute carrier family 12, member 5 N/E
PDE4D phosphodiesterase 4D NE, interior cerebellum
IQSEC1 IQ motif and Sec7 domain 1 N/E
CNTNAP2 contactin associated protein-like 2 RL specific
CNPY1 canopy 1 homolog N/A
MAPK8IP1 mitogen activated protein kinase 8 interacting protein 1 specific cerebellar nuclei, spinal cord
DLGAP4 discs, large homolog-associated protein 4 widespread cerebellum
ANK3 ankyrin 3, epithelial interior cerebellum
CACNB4 calcium channel, voltage-dependent, beta 4 subunit N/E
ANP32a acidic (leucine-rich) nuclear phosphoprotein 32 family strong, EGL & NE specific staining
TMX3 thioredoxin-related transmembrane protein 3 N/A
APBB3 amyloid beta (A4) precursor protein-binding, family B, member 3 N/E
PRMT8 protein arginine N-methyltransferase 8 widespread cerebellum
EDNRB Mus musculus endothelin receptor type B strong NE specific staining
SEMA4G sema domain 4G widespread cerebellum
FBLN5 fibulin 5 N/E
ZRANB1 zinc finger, RAN-binding domain containing 1 N/E
ZBTB38 zinc finger and BTB domain containing 38 N/A
IBTK inhibitor of Bruton agammaglobulinemia tyrosine kinase N/E
GPC6 glypican 6 Strong NE, NTZ specific staining
HSPH1 heat shock 105 kDa/110 kDa protein 1 N/A
ZFP451 Mus musculus zinc finger protein 451 moderate EGL staining
GRAMD1B GRAM domain containing 1B N/E
N/E not expressed or ineffective probe, NE neuroepithelium, RL Rhombic lip, EGL external granular layer, NTZ nuclear transitory zone, N/A data not available
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Fig. 5 Alternative TSSs in glypican 6 (Gpc6) and experimental validation of its non-crossover switching events with Real-time PCR. a Schematic
DNA structure of Gpc6, alternative mRNA variants and un-altered protein structure. b in situ expression of Gpc6 in mouse cerebellum at E14.5
(from GenePaint). c HeliscopeCAGE expression data for the two alternative TSSs during cerebellar development. X-axis: time, from embryonic day 11 (E11)
to postnatal day 9 (P9). Y-axis: expression level measured in tpm (tags per million). d qRT-PCR expression data demonstrating a non-crossover TSS switching
event between E15 and P9. X-axis: time at E12, E15 and P9. Y-axis: expression level measured in RQ (relative quantity against H2O as negative control)
Fig. 6 Alternative TSSs in Acidic nuclear phosphoprotein 32 family, member A (Anp32a) and experimental validation of its crossover switching
events with Real-time PCR. a Schematic DNA structure of Anp32a, alternative mRNA variants and altered protein structure at the N-terminus.
b in situ expression of Anp32a in mouse cerebellum at E14.5 (from GenePaint). c HeliscopeCAGE expression data for the two alternative TSSs
during cerebellar development. X-axis: time, from embryonic day 11 (E11) to postnatal day 9 (P9). Y-axis: expression level measured in tpm
(tags per million). d qRT-PCR expression data demonstrating a crossover TSS switching events between E12 and P9. X-axis: time at E12, E15
and P9 Y-axis: expression level measured in RQ (relative quantity against H2O as negative control)
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guanine nucleotide binding protein (GNAS), alternative
promoters were shown to be activated or silenced [29].
However, the focus of previous studies has been the
tissue-specific transcriptional regulation of alternative
promoters; the temporal aspect of alternative promoter
usage during cerebellar development has been over-
looked. Our analyses focused on the switching usage of
alternative promoter in the mouse cerebellum, and this
is the first systematic study of alternative promoter
usage in the development of the mouse cerebellum.
Temporal regulation of alternative TSS associated with
developmental processes in the cerebellum
Alternative TSSs reflect different promoter regions
that can be used for tissue-specific and/or temporal-
specific expression. For example, albumin in hepato-
cytes has several cis-acting elements that recruit different
sets of trans-acting factors, which enable spatial, temporal
and dynamics regulation of the transcription of albu-
min mRNA [30]. In this study, we have identified 9767
crossover TSS switching events in 1511 genes. Thus, in
~20% of genes there is more than one promoter that is
used dominantly during cerebellar development. Func-
tional annotation analysis for these genes revealed GO
terms that are expected to be associated with alterna-
tive promoter usage, such as “alternative splicing” and
“splicing variants”, as well GO terms that point to
processes where promoter switching might play a role
during development, such as “phosphoprotein”,
“cytoskeleton organization” and “neuron projection”.
Phosphoproteins are involved in the post-translational
regulatory process phosphorylation, in which a phos-
phate group is added to a peptide. The physical
binding of phosphoproteins, such as Fas-activated
serine/threonine phosphoprotein (FAST), to regulators
of alternative splicing has been evidenced by yeast
two-hybrid screening and biochemical analyses [31].
Furthermore, the sensory, motor, integrative, and adap-
tive functions of neuron projections are associated
with the development of a growth cone, which is com-
posed primarily of an actin-based cytoskeleton [32].
One of the cytoskeleton remodeling genes, Disabled-1
(Dab1), has multiple isoforms, as a result of alternative spli-
cing [33], that are activated by tyrosine-phosphorylation
and play important roles in neuronal positioning by
recruiting a wide range of SH2 domain-containing
proteins and activates downstream protein cascades
through the Reelin signalling pathway [34]. Deficiency
in Dab1 pathway resulted in a delay in the develop-
ment of Purkinje cell dendrites and dysregulation of
the synaptic markers of parallel fiber and climbing
fiber in the cerebellum [35].
Fig. 7 Alternative TSSs in contactin associated protein-like 2 (Cntnap2) and experimental validation of its crossover switching events with Real-time
PCR. a Schematic DNA structure of Cntnap2, alternative mRNA variants and truncated protein structure of the short isoform. b in situ expression of
Cntnap2 in mouse cerebellum at E14.5 (from GenePaint). c HeliscopeCAGE expression data for the two alternative TSSs during cerebellar development.
X-axis: time, from embryonic day 11 (E11) to postnatal day 9 (P9). Y-axis: expression level measured in tpm (tags per million). d qRT-PCR expression data
demonstrating a crossover TSS switching events between E12 (as well as E15) and P9. X-axis: time at E12, E15 and P9. Y-axis: expression level measured
in RQ (relative quantity against H2O as negative control)
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The dominant TSS usually switches gradually over time
so that only 3.7% of crossover TSS switching are detected
at adjacent time points (357 of 9767 events). However,
more than a quarter of the changes at adjacent time points
occur between E12-E13 (93 out of 357). This time period
coincides with key developmental events such as cell spe-
cification, cell proliferation of granule cell precursors in
the rhombic lip, as well as the initiation of cells migrating
toward the anterior end of the cerebellum [36].
Alternative TSS as post-transcriptional control during
cerebellar development
Alternative TSSs can produce distinct mRNA isoforms
that have different RNA stability and translational effi-
ciency of the mRNA isoforms. For example, Vascular
Endothelial Growth Factor A (VEGF-A) mRNA stability
is regulated through alternative initiation codons that
are generated through usage of alternative promoters
[37]. We found that two alternative forms of Anp32a are
dominantly expressed at different developmental stages in
the cerebellum. The long form has 12 additional amino
acids on the N-terminus compared to the short form. This
difference could alter ANP32A protein stability and distri-
bution. The role of Anp32a during cerebellar development
is not known, but it is found to be involved in a variety of
cellular processes in both nucleus and cytoplasm, including
signaling, apoptosis, protein degradation, and mor-
phogenesis [38]. Moreover, Anp32a is known to be a
key component of the inhibitor of acetyltransferase
(INHAT) complex in the nucleus, involved in regulating
chromatin remodeling or transcription initiation [39].
There are suggestions that Anp32a may play important
roles in the brain as the level of Anp32a is increased in
Alzheimer’s disease and may be involved in the regulatory
mechanism of affecting Tau phosphorylation and impairing
the microtubule network and neurite outgrowth [40].
Alternative TSSs can also be a means of producing
mRNA isoforms with various mRNA stability and transla-
tion efficiency. In the case of Gpc6, we found that its two
forms only differ in mRNA sequence that could affect its
mRNA stability and translation efficiency. Gpc6 is most
abundantly expressed in the ovary, liver, and kidney, with
low level expression in the nervous system [41]. In mice,
Gpc6 is critical to modulating the response of the growth
plate to thyroid hormones [42]; while in human, muta-
tions in the region where Gpc6 resides on Chromosome
13 are associated with defects in endochondral ossification
and cause recessive omodysplasia [43].
Functional importance of alternative TSS during
cerebellar development
Alternative TSSs can produce protein isoforms with dis-
tinct N-termini; this in turn would lead to alterations in
protein function. An example would be the secreted and
membrane-bound isoforms of mammalian Fos-responsive
gene, Fit-1, that are generated and regulated by a pair of
alternative promoters [44]. We found that during cerebel-
lar development, the short form of Cntnap2 loses most of
the functional domains present in the long form – with
only the last laminin G domain retained. Cntnap2 has
been found to play a role in the local differentiation of the
axon into distinct functional subdomains [45]. The func-
tion of Cntnap2 short form during cerebellar development
is still to be investigated, but the lack of most functional
domains suggest its role as a transcriptional suppressor –
through mechanism such as non-sense mediated decay
[46]; or a functional competitor for the same domain
binding region [47], for Cntnap2 long form counterpart
during early development. During postnatal development,
the short form of Cntnap2 ceases to be expressed and the
long (and presumably fully functional) form is maintained
at a steady level. Cntnap2 is strongly associated with
autism spectrum disorders, shown in previous studies
[48–50]. A knockout mouse for Cntnap2 targeted the
gene’s first exon and completely eliminated the expression
of the long form [51], which caused abnormalities in body
size, neuronal migration and activity, and behaviour. Thus
the knockout has been used as an animal model for
autism [52, 53]. However, the short form of Cntnap2
should be present in the knockout, and no attention has
been directed to the expression of the short form in the
knockout. A mutation targeted to the C-terminus would
be required to reveal Cntnap2’s overall function in con-
sidering both its long and short protein isoforms.
Conclusion
We analyzed the cerebellar developmental time course
data from the FANTOM5 project and identified 9767
TSS switching events with temporally specific dominant
promoters. This is the first study to investigate the
prevalence of alternative TSS usage during cerebellar de-
velopment and their potential roles in transcriptional,
post-transcriptional and functional regulation.
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